Boundless Bio (BOLD) Earnings Date & Reports

Boundless Bio Inc is a clinical-stage oncology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BOLD is expected to report earnings to rise 37.84% to -101 cents per share on May 19

Boundless Bio BOLD Stock Earnings Reports

Q1'25

Est.

$-1.02

Q4'24

Beat

by $0.10

Q3'24

Missed

by $0.01

Q2'24

Missed

by $0.12

The last earnings report on March 27 showed earnings per share of -74 cents, beating the estimate of -83 cents. With 87.39K shares outstanding, the current market capitalization sits at 27.21M.

View a ticker or compare two or three

Compare

BOLD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BOLD
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of gene therapy products for patients with serious rare diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9880 Campus Point Drive

Phone

+1 858 766-9912

Employees

Web

https://www.boundlessbio.com